Berlin Heart Announces Restructuring of Management
BERLIN, July 7 /PRNewswire/ -- Ulrich Stroeher, Chairman of the Advisory
Board of Berlin Heart, today announced that Dr. Johannes Mueller is leaving
the general management of the company on 30 September 2009.
Dr. Mueller belongs to the company's founders and is one of the
Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsuka's Pharmaceutical Business Worldwide Restructuring
efforts include the re-alignment of shared services, including Business Technology, and establishment of Pharmaceutical Governance and Medical Device Governance Committees
ROCKVILLE, Md. and PRINCETON, N.J., Feb. 25 /PRNewswire/ -- Otsuka America Pharmaceutical, Inc. (OAPI) and ...
Vical Announces Strategic Restructuring and Staff Reduction
SAN DIEGO, Nov. 21 /PRNewswire-FirstCall/ -- Vical Incorporated
(Nasdaq: VICL ) today announced a strategic restructuring
including a staff
reduction of 29 employees, approximately 20% of the company's total workforce,
and accelerated closure of a research facility. Following the restructuring,
Replidyne Announces Restructuring of Operations
LOUISVILLE, Colo., Aug. 27 /PRNewswire-FirstCall/ -- Replidyne, Inc.
(Nasdaq: RDYN ) today announced the restructuring
of its operations reducing
its current employee headcount by approximately 80% to 5 employees in
actions that are scheduled to take place during September 2008 and October
Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital
Aduromed Begins Next Step in Corporate Evolution, Restructuring
the Company and Augmenting its Board and Management Team
BETHEL, Conn., Aug. 6 /PRNewswire-FirstCall/ -- Aduromed Industries,
Inc. (OTC Bulletin Board: ADRM) a leading manufacturer of medical waste
treatment systems, to...
Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008
BOTHELL, Wash., Feb. 29 /PRNewswire-FirstCall/ -- Nastech
Pharmaceutical Company Inc. (Nasdaq: NSTK ) announced today that it will
host a conference call with investors and security analysts on Monday,
March 3, 2008, at 11:30 a.m. Eastern time (8:30 a.m. Pacific time) to
discuss the Company's...
IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
IRVINE, Calif., Dec. 31 /PRNewswire-FirstCall/ -- IDM Pharma, Inc.
(Nasdaq: IDMI ) today announced that as part of the Company's recent
decision to evaluate strategic alternatives, the Company initiated
discussions with sanofi-aventis. Following this, sanofi-aventis has
notified the Company o...
Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs
Company to Host Webcast and Conference Call
BOTHELL, Wash., Nov. 13 /PRNewswire-FirstCall/ -- Nastech
Pharmaceutical Company Inc. ("Nastech") (Nasdaq: NSTK ) announced today its
initiatives aimed at reducing operating expenses
and enhancing shareholder va...
Brotman Medical Center Facilitates Restructuring Through Chapter 11 Filing
CULVER CITY, Calif., Oct. 26 /PRNewswire/ -- Brotman Medical Center, a
privately held, 420-bed medical center serving the West Los Angeles area,
announced today that it has filed a voluntary Chapter 11 petition in the
United States Bankruptcy Court for the Central District of California in
QLT Inc. announces initial steps in strategic restructuring
VANCOUVER, Jan. 16 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI;
TSX: QLT) today announced that following a months-long business and
portfolio review, the Board of Directors has decided to implement several
new initiatives designed to enhance shareholder value.
These initiatives include...
Restructuring in Medical Technology
Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
Conference Call Scheduled for November 11, 2008 at 9:00 am ET
SOUTH SAN FRANCISCO, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Anesiva,
Inc. (Nasdaq: ANSV ) today announced that the ACTIVE-1 Phase 3 trial
evaluating Adlea(TM), a novel formulation of capsaicin, narrowly missed its
Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
...ry focus on the continued development of AZ-004 ( Staccato loxapine). The restructuring
included a workforce reduction of 50 employees, representing approximately ... General and administrative 3,864 4,462
charges 1,528 -
Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
...r of 2009 include a charge of $1.1 million for the restructuring
and related asset impairment resulting from the Company's strategic restructuring
plan to discontinue its in-house preclinical resea...d administrative 3,084 4,183
& asset impairment 1,056 -
Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
administrative(b) 14,860 16,125 60,865 55,874
Lease termination and
credits - - - (3,673)
Total costs and
expenses 63,376 103,437 303,575 ...
Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
...ain the company's emphasis on its active preclinical and clinical
programs, while conserving the company resources. The company is still
assessing the restructuring
and other charges associated with this measure,
which is expected to be predominantly recorded in the first quarter of 2009.
As of December 31, 2008, ...
American Dairy Provides Business Update
The Company also announced that, as part of the restructuring
of the Company's outstanding 1% Guaranteed Senior ...pended, as of November 13, 2008, the date that the restructuring
took effect, provided that the Company completes t...fied deadlines in accordance with the terms of the restructuring
agreement. In the event that the Company does not...
Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
..., president and CEO. "Based on this
review we are refining our strategy and restructuring
operations to drive
the company toward long-term success."
"We believe th...elopment and outsourced manufacturing. Anesiva
expects to record a one-time restructuring
charge of approximately $0.7
million in the third quarter of 2008. Anesiva ...
CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
... Research and development 3,635 10,904 9,006 22,406 General and administrative 1,443 3,049 3,159 7,063 restructuring
and other charges - 7,479 - 7,479 Total operating expenses 5,078 21,432 12,165 36,948
Gain on sale of...
Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
Approximately $2.5 million of the restructuring
charge represents cash
payments over the next twel...lated to the expected timing for completion
of the restructuring
plan; estimated restructuring
charges to be incurred
by Sunesis in the second qu...
Neurocrine Biosciences Reports First Quarter 2008 Results
...ch and development expenses is primarily due to
cost savings related to our restructuring
in the fourth quarter of 2007.
General and administrative expenses were $...lion during the same period last year. The
Company incurred $2.2 million in restructuring
charges during the first
quarter of 2008. This cost was offset by cost savi...
Restructuring in Biological News
Public trust doctrine could aid management of US oceans
...ould be an effective and ethical solution to this and similar conflicts.
"The public trust doctrine could provide a practical legal framework for restructuring
the way we regulate and manage our oceans. It would support ocean-based commerce while protecting marine species and habitats," says lead author Mary ...
Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008
...xcluding the effects of the net change in accrued restructuring
Revenues for the fourth...ion, generated $12 million of cash flow (excluding restructuring
charges), and increased our subscription based pro... write-down of long-term assets and adjustments to restructuring
accruals. See the financial table below reconcilin...
CSHL researchers map changing epigenetic modifications that enable transposons to run amok
... shouldn't be and shut off the activity of genes that are essential. The team's epigenetic profiling study now implicates siRNA-driven heterochromatin restructuring
as a mechanism that might lead to epiallele formation.
Orchid Cellmark Reports Third Quarter 2008 Financial Results
...ting and sales 1,536 1,503 4,659 4,500
General and administrative 3,588 3,831 12,639 11,747
- (75) - (75)
Amortization of intangible assets 475 447 1,429 1,337
Entomological Society of America names new Fellows for 2008
...h Central Branch (1998), on the Governing Board (1990-1993, 2000-2005), as ESA President (2004), and as a member of numerous committees, including the restructuring
Advisory Council (2006-2007). He was co-editor of the ESA's Handbook of Corn Insects , published in 1999. "I have been recognized several times by th...
Cocaine: How addiction develops
...s in the brain: In particular regions of the central nervous system, which produce the messenger substance dopamine, the drug cocaine causes molecular restructuring
processes at the synapses, the points of connection between two neurons. As a reaction to the drug, protein subunits are exchanged in specific recepto...
Shell-breaking crabs lived 20 million years earlier than thought
...esearch Institution in Ithaca. "I was really excited when I found it. The fossil re-opens the
question of the role crabs played in the
of marine communities that occurred during the Mesozoic era [251 million years ago to 65 million years ago]."
The discovery led to a study, publish...
Is hybridoma production about to take a quantum leap forward?
...blocked by the basic difference between regular water and intracellular water, can now cross the "molecular water barrier", thanks to the nanoparticle restructuring
capability of Neowater®. We can expect a new era in R&D as these concepts are facilitated by Neowater® technology and find realization in the...
Recovering from a mass extinction
...s with a backbone and four legs, such as amphibians and reptiles and found that although globally tetrapods appeared to recover quickly, the dramatic restructuring
that occurred at the community level was not permanent and communities did not recover numerically or ecologically until about 30 million years later....
Oak Ridge to lead auto supplier R&D partnership
...enter with established laboratory infrastructure that will support up to 175 people. Delphi Corporation is vacating this facility under its corporate restructuring
An organizing board has been formed to govern USAutoPARTs and its research mission. Those participating include: Automation Alley, the Cen...
Restructuring in Biological Technology
Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today announced a strategic restructuring
to focus its operations on the development of ANA598, in particular a proposed Phase II study in hepatitis C patients of ANA598 in combination with pegylated int...
Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock
MONTVALE, N.J., Feb. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that it has entered into agreements with the current holders of its Series B Preferred Stock, $0.01 par value per share, under which $2,875,000 in accrued dividend obligations r...
XTL Biopharmaceuticals Implements Restructuring Plan
VALLEY COTTAGE, N.Y., Dec. 8 /PRNewswire-FirstCall/ -- XTL
Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announced today that it is
restructuring its operations following the failure of the Bicifadine Phase 2b
clinical trial. The company is terminating the employment of 9 employees,
Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction
Changes will result in over $80 million reduction in 2009 cash expenditures
SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (Nasdaq: AMLN ) today announced a corporate restructuring
reduce its San Diego workforce by approximately 25 percent, or 340
ADVENTRX Announces Restructuring and Cost Reduction Initiatives
- CEO Resigns; Executive Team Reorganized; 27% Reduction in Force - Timelines Revised for ANX-530 and ANX-514
- Company to Present Updated Corporate Outlook at Conferences in October
SAN DIEGO, Oct. 20 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals,
Inc. (Amex: ANX ) ann...
Vasogen Announces Implementation of Strategic Restructuring Plan
MISSISSAUGA, ON, April 14 /PRNewswire-FirstCall/ - Vasogen Inc.
(NASDAQ: VSGN ; TSX:VAS), today announced that it has implemented a strategic
restructuring plan to significantly reduce its cash burn rate and focus its
efforts on opportunities that the Board and management believe are most
Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
Plan includes refocusing of operations and workforce reduction
NEW YORK, April 4, 2008 /PRNewswire-FirstCall/ -- Keryx
Biopharmaceuticals (Nasdaq: KERX ) today announced that it is implementing a
plan to reduce its cash burn rate and re-focus its
Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
SAN CARLOS, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Nektar
Therapeutics (Nasdaq: NKTR ) announced a restructuring
today designed to
complete its transition from a drug delivery service provider to a
therapeutics drug development organization. The restructuring
streamline the company, c...
Neurocrine Announces Work Force Restructuring
SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today staff reductions of approximately 60 employees, as a part of its restructuring
program to focus the Company's efforts on its clinical programs and pre-clinical development leads. Following th...
Trubion Pharmaceuticals Inc. Announces Work-Force Reductions and Restructuring
SEATTLE, Feb. 25 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc.
(Nasdaq: TRBN ) today announced a work-force reduction of approximately 25
percent, or 25 employees, and a corporate restructuring. In the face of
continuing uncertainty in the capital markets and the global economy, Tru...
Restructuring in Biological Definition
...f embryonic development is seen in all animals except the sponges . It follows the blastula phase. The gastrula phase is marked by a dramatic restructuring
called gastrulation . After gastrulation is complete, the embryo develops into a neurula .